ORCA
Online Research @ CardiffÂ
Browse by Current Cardiff authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 5.
Russell, Nigel H., Thomas, Abin  ORCID: https://orcid.org/0000-0002-8283-6762, Hills, Robert K., Thomas, Ian, Gilkes, Amanda, Marquez Almuina, Nuria, Burns, Sarah, Marsh, Lucy, Vyas, Paresh, Metzner, Marlen, McCarthy, Nicholas, Andrew, Georgia, Byrne, Jennifer, Sellar, Rob S., Kelly, Richard, Cahalin, Paul, Malthe Overgaard, Ulrik, Mehta, Priyanka, Dennis, Mike, Knapper, Steven ORCID: https://orcid.org/0000-0002-6405-4441 and Freeman, Sylvie D.
2024.
Treatment intensification with either fludarabine, AraC, G-CSF and idarubicin, or cladribine plus daunorubicin and AraC on the basis of residual disease status in older patients With AML: Results From the NCRI AML18 Trial.
Journal of Clinical Oncology
10.1200/JCO.24.00259
|
|
|
|
Freeman, Sylvie D, Thomas, Abin, Thomas, Ian, Vyas, Paresh, Gilkes, Amanda, Metzner, Marlen, Jakobsen, Niels Asger, Kennedy, Alison, Moore, Amy, Marquez Almuina, Nuria, Burns, Sarah, King, Sophie, Andrew, Georgia M., Gallagher, Kathleen M.E., Sellar, Rob, Cahalin, Paul, Weber, Duruta, Dennis, Mike, Mehta, Priyanka, Knapper, Steve ORCID: https://orcid.org/0000-0002-6405-4441 and Russell, Nigel H.
2022.
A randomized comparison of the fractionated versus single dose schedule of Gemtuzumab Ozogamicin at induction with determinants of benefit for older AML patients: UK NCRI AML18 trial results.
Blood
140
(S1)
, pp. 532-533.
10.1182/blood-2022-162245
|
|
|
Burnett, Alan Kenneth, Russell, N. H., Hills, Robert Kerrin ORCID: https://orcid.org/0000-0003-0166-0062, Kell, J., Nielsen, O. J., Dennis, M., Cahalin, P., Pocock, C., Ali, S., Burns, Sarah, Freeman, S., Milligan, D. and Clark, R. E.
2017.
A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia.
Leukemia
31
(2)
, pp. 310-317.
10.1038/leu.2016.225
|
|
|
|
Macbeth, Fergus R., Griffiths, Gareth O., Noble, Simon Ian Robert ORCID: https://orcid.org/0000-0001-5425-2383, Burns, Sarah and Maughan, Timothy Stanley
2009.
Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin® added to standard therapy in patients with lung cancer [Abstract].
Journal of Thoraric Oncology
4
(9)
, S5-S968.
10.1097/JTO.0b013e3181b9c77e
|
|
|
|
Griffiths, Gareth O., Burns, Sarah, Noble, Simon Ian Robert ORCID: https://orcid.org/0000-0001-5425-2383, Macbeth, Fergus R, Cohen, David and Maughan, Timothy Stanley
2009.
Fragmatic: a randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer.
BMC Cancer
9
, pp. 355-363.
10.1186/1471-2407-9-355
|
|
|
Cardiff University Information Services